4.7 Article

Automatic morphometry in Alzheimer's disease and mild cognitive impairment

Journal

NEUROIMAGE
Volume 56, Issue 4, Pages 2024-2037

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2011.03.014

Keywords

Image segmentation; Brain pathology; Brain atlas; Magnetic resonance imaging; Alzheimer's disease; Mild cognitive impairment

Funding

  1. National Institutes of Health
  2. Abbott
  3. AstraZeneca AB
  4. Bayer Schering Pharma AG
  5. Bristol-Myers Squibb
  6. Eisai Global Clinical Development
  7. Elan Corporation
  8. Genentech
  9. GE Healthcare
  10. GlaxoSmithKline
  11. Innogenetics
  12. Johnson Johnson
  13. Eli Lilly and Co.
  14. Merck Co., Inc.
  15. Novartis AG
  16. Pfizer Inc.
  17. F. Hoffmann-La Roche
  18. Schering-Plough
  19. Synarc Inc.
  20. Wyeth
  21. Alzheimer's Association
  22. Institute for the Study of Aging
  23. Dunhill Medical Trust, UK
  24. MRC [G108/585, MC_U120061309] Funding Source: UKRI
  25. Medical Research Council [G108/585, MC_U120061309] Funding Source: researchfish

Ask authors/readers for more resources

This paper presents a novel, publicly available repository of anatomically segmented brain images of healthy subjects as well as patients with mild cognitive impairment and Alzheimer's disease. The underlying magnetic resonance images have been obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. T1-weighted screening and baseline images (1.5 T and 3 T) have been processed with the multi-atlas based MAPER procedure, resulting in labels for 83 regions covering the whole brain in 816 subjects. Selected segmentations were subjected to visual assessment. The segmentations are self-consistent, as evidenced by strong agreement between segmentations of paired images acquired at different field strengths (Jaccard coefficient: 0.802 +/- 0.0146). Morphometric comparisons between diagnostic groups (normal; stable mild cognitive impairment; mild cognitive impairment with progression to Alzheimer's disease; Alzheimer's disease) showed highly significant group differences for individual regions, the majority of which were located in the temporal lobe. Additionally, significant effects were seen in the parietal lobe. Increased left/right asymmetry was found in posterior cortical regions. An automatically derived white-matter hypointensities index was found to be a suitable means of quantifying white-matter disease. This repository of segmentations is a potentially valuable resource to researchers working with ADNI data. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available